SG Americas Securities LLC Acquires Shares of 61,735 Liquidia Technologies, Inc. (NASDAQ:LQDA)

SG Americas Securities LLC acquired a new position in shares of Liquidia Technologies, Inc. (NASDAQ:LQDA - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 61,735 shares of the company's stock, valued at approximately $911,000. SG Americas Securities LLC owned 0.07% of Liquidia Technologies at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Corebridge Financial Inc. increased its position in shares of Liquidia Technologies by 2.3% in the 4th quarter. Corebridge Financial Inc. now owns 31,516 shares of the company's stock valued at $371,000 after acquiring an additional 694 shares during the period. GAMMA Investing LLC increased its holdings in shares of Liquidia Technologies by 65.6% in the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after purchasing an additional 1,173 shares during the period. Cetera Investment Advisers raised its stake in shares of Liquidia Technologies by 4.3% in the fourth quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock worth $367,000 after purchasing an additional 1,277 shares during the last quarter. Summit Investment Advisors Inc. raised its stake in shares of Liquidia Technologies by 35.0% in the fourth quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company's stock worth $78,000 after purchasing an additional 1,719 shares during the last quarter. Finally, Sigma Planning Corp lifted its holdings in shares of Liquidia Technologies by 3.4% during the fourth quarter. Sigma Planning Corp now owns 65,210 shares of the company's stock worth $767,000 after purchasing an additional 2,115 shares during the period. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Liquidia Technologies Price Performance

Shares of LQDA stock traded up $0.05 during trading hours on Thursday, hitting $13.64. 1,463,501 shares of the company's stock were exchanged, compared to its average volume of 1,214,854. Liquidia Technologies, Inc. has a fifty-two week low of $8.26 and a fifty-two week high of $19.41. The firm has a market cap of $1.17 billion, a P/E ratio of -8.63 and a beta of 0.04. The company has a quick ratio of 2.91, a current ratio of 2.93 and a debt-to-equity ratio of 2.08. The firm has a 50 day moving average of $15.24 and a two-hundred day moving average of $14.17.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). The company had revenue of $3.12 million for the quarter, compared to analyst estimates of $3.23 million. Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. Sell-side analysts forecast that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on LQDA shares. HC Wainwright increased their price target on shares of Liquidia Technologies from $29.00 to $35.00 and gave the stock a "buy" rating in a report on Wednesday, May 28th. Oppenheimer set a $13.00 price objective on shares of Liquidia Technologies and gave the company an "underperform" rating in a report on Monday, May 19th. Wells Fargo & Company raised their target price on shares of Liquidia Technologies from $23.00 to $25.00 and gave the stock an "overweight" rating in a report on Thursday, June 12th. Scotiabank boosted their target price on shares of Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a research report on Wednesday, May 28th. Finally, Wall Street Zen raised shares of Liquidia Technologies from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $26.89.

Insider Transactions at Liquidia Technologies

In other Liquidia Technologies news, CFO Michael Kaseta sold 8,283 shares of the firm's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $13.57, for a total value of $112,400.31. Following the transaction, the chief financial officer now owns 396,315 shares in the company, valued at approximately $5,377,994.55. This trade represents a 2.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Rajeev Saggar sold 2,450 shares of Liquidia Technologies stock in a transaction on Monday, April 21st. The stock was sold at an average price of $13.67, for a total transaction of $33,491.50. Following the sale, the insider now directly owns 263,152 shares in the company, valued at approximately $3,597,287.84. This trade represents a 0.92% decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,138 shares of company stock valued at $450,233 over the last 90 days. Corporate insiders own 26.50% of the company's stock.

Liquidia Technologies Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).